(2005) (2 R)-4-Oxo-4-[3-(trifluoromethyl)-5, 6-dihydro [1, 2, 4] triazolo [4, 3-a] pyrazin-7 (8 H)-yl]-1-(2, 4, 5-trifluorophenyl) butan-2-amine: a Potent, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes
However, there is an additional consideration
Caffeine/stimulants: Caffeine and other stimulant ingredients are often added to weight-loss products and when ingested, can cause agitation, hyperactivity, tremors/seizures and heart rhythm abnormalities
In this study, the MRS device operated at a high electric-field intensity to deliver especially precise and well-resolved measurements of the targeted metabolites
You may also notice delayed or weaker appetite suppression if medication absorption is compromised by poor technique or scar tissue buildup